½ÃÀ庸°í¼­
»óǰÄÚµå
1378570

¼¼°è ¹Ì³ì½Ãµô ½ÃÀå : À¯Çüº°, Åõ¿© °æ·Îº°, ³²³àº°, À¯Åë ä³Îº°, Áö¿ªº°

Minoxidil Market, By Type, By Route of Administration, By Gender, By Distribution Channel, By Region

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¹Ì³ì½Ãµô ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 10¾ï 9,550¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 4.8%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

º¸°í ´ë»ó ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁسâ 2022³â 2023³â ½ÃÀå ±Ô¸ð 10¾ï 9,550¸¸ ´Þ·¯
¾÷Àû µ¥ÀÌÅÍ 2018³â-2021³â ¿¹Ãø ±â°£ 2023-2030
¿¹Ãø ±â°£ÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 4.80% 2030³â ½ÃÀå ±Ô¸ð ¿¹Ãø 15¾ï 2,110¸¸ ´Þ·¯
±×¸² 1. ¼¼°è ¹Ì³ì½Ãµô ½ÃÀå Á¡À¯À²(%), À¯Çüº°(2030³â)
Minoxidil Market-IMG1

¹Ì³ì½ÃµôÀº °íÇ÷¾Ð°ú Å»¸ðÀÇ Ä¡·á¿¡ »ç¿ëµÇ´Â ÀǾàǰÀÔ´Ï´Ù. °­¾Ð Ç÷°ü È®ÀåÁ¦ÀÔ´Ï´Ù. Á¦³×¸¯ ÀǾàǰÀ¸·Î¼­, ó¹æÀü¿¡ ÀÇÇØ °æ±¸ Á¤Á¦·Î¼­, ¶Ç ¸ÅÀå¿¡¼­´Â ¿Ü¿ë¾×Á¦ ¶Ç´Â ÆûÁ¦·Î¼­ ÀÔ¼ö °¡´ÉÇÕ´Ï´Ù. ¹Ì³ì½ÃµôÀº °­¾Ð ¿Ü¿ëÁ¦·Î ¹ß¸ð¸¦ ÃËÁøÇÕ´Ï´Ù. ¹Ì³ì½ÃµôÀº ÁÖ·Î ³²¼ºÇü Å»¸ðÁõÀÇ Ä¡·áÁ¦·Î ó¹æµÇ¸ç ´Ù¸¥ Å»¸ðÁõÀÇ ÀûÀÀ ¿Ü Ä¡·áÁ¦·Îµµ »ç¿ëµË´Ï´Ù. ¹Ì³ì½ÃµôÀº ¹Ì±¹ ½ÄǰÀǾ౹(FDA) Àΰ¡ÀÇ 2% ¹Ì³ì½Ãµô ¿ë¾×À¸·Î, 1986³â¿¡ óÀ½À¸·Î ½ÃÀå¿¡ ÅõÀԵǾî 1993³â¿¡´Â 5% ¿ë¾×ÀÌ ¹ß¸ÅµÇ¾ú½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®´ëÇϱâ À§ÇØ Á¦Ç° ½ÃÀå°ú °°Àº À¯±âÀû ¼ºÀå Àü·«À» äÅÃÇÏ´Â °æ¿ì°¡ ´Ã¾î³ª´Â °ÍÀ¸·Î ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 11¿ù ¹Ì±¹ ÃÖ´ëÀÇ ¸ð¹ß Àç»ý ±â¾÷ÀÎ Bosley»ç´Â ³²¼º¿ë ó¹æ Å»¸ðÁ¦ÀÇ Çö´ëÀûÀÎ Á¢±Ù ¹æ½ÄÀÎ BosleyRx¸¦ Ãâ½ÃÇß½À´Ï´Ù. °£´ÜÇÑ ¿Â¶óÀÎ ÇÁ·Î¼¼½º¸¦ ÅëÇØ °æÇèÀÌ Ç³ºÎÇÑ ÀÇ·á Àü¹®°¡°¡ Å»¸ð ¿¹¹æ¡¤¹ß¸ð Ä¡·á¸¦ Áø´Ü¡¤Ã³¹æÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • º» º¸°í¼­¿¡¼­´Â ¼¼°è ¹Ì³ì½Ãµô ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2022³âÀ» ±âÁسâÀ¸·Î ÇÑ ¿¹Ãø±â°£(2023-2030³â) ½ÃÀå ±Ô¸ð ¹× º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)À» Á¦°øÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ¼ºÀå ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀå¿¡ ´ëÇÑ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾ÈÀÇ Çà·Ä¿¡ ´ëÇØ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ ÁÖ¿ä °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ¿£ÅÍÇÁ¶óÀÌÁî ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¹Ì³ì½Ãµô ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • º» Á¶»çÀÇ ´ë»óÀÌ µÇ´Â ÁÖ¿ä ±â¾÷Àº Pfizer Inc., Atom pharma, Perrigo Company plc, Johnson and Johnson Services, Inc., Merck KGaA, Actavis Pharma, Inc., Apotex Inc., UltiMed Inc., DS LABORATORIES, INC., ´ÙÀ̼î Á¦¾à ÁÖ½Äȸ»ç, NIKSAN PHARMACEUTICAL, SALVAVIDAS PHARMACEUTICAL PVT.Ltd., Maruti Futuristic Pharma Pvt.Ltd., Sun Pharmaceutical Industries Ltd., Dr. Unison Pharmaceuticals Pvt Ltd., Par Pharmaceutical, QndQ Derma.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®À» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, ŸÀÌÇÎ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¼¼°è ¹Ì³ì½Ãµô ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¹Ì³ì½Ãµô ½ÃÀåÀ» ºÐ¼®Çϴµ¥ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ¿ëÀÌÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦

  • Á¶»çÀÇ ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ±âȸ
  • ¿µÇ⠺м®
  • ÃÖ±Ù Å×½ºÆ® ¹ß»ç
  • ¿ªÇÐ
  • ÇÕº´, Àμö ¹× Çù¾÷
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ÁÖ¿ä ¹ßÀü
  • PEST ºÐ¼®

Á¦4Àå ¼¼°è ¹Ì³ì½Ãµô ½ÃÀå : COVID-19 °¨¿°ÁõÀÇ ¿µÇ⠺м®

  • °æÁ¦Àû ¿µÇâ
  • ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)ÀÇ ¿ªÇÐ
  • ¼ö¿ä ¹× °ø±Þ¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå ¼¼°è ¹Ì³ì½Ãµô ½ÃÀå : À¯Çüº°(2018-2030³â)

  • ¼Ò°³
  • 5% ¹Ì³ì½Ãµô
  • 2% ¹Ì³ì½Ãµô

Á¦6Àå ¼¼°è ¹Ì³ì½Ãµô ½ÃÀå : Åõ¿© °æ·Îº°(2018-2030³â)

  • ¼Ò°³
  • °æ±¸
  • ¿Ü¿ë

Á¦7Àå ¼¼°è ¹Ì³ì½Ãµô ½ÃÀå : ³²³àº°(2018-2030³â)

  • ¼Ò°³
  • ³²¼º
  • ¿©¼º

Á¦8Àå ¼¼°è ¹Ì³ì½Ãµô ½ÃÀå : À¯Åë ä³Îº°(2018-2030³â)

  • ¼Ò°³
  • º´¿ø ¾à±¹
  • ¼Ò¸Å ¾à±¹
  • ¿Â¶óÀÎ ¾à±¹

Á¦9Àå ¼¼°è ¹Ì³ì½Ãµô ½ÃÀå : Áö¿ªº°(2018-2030³â)

  • ¼Ò°³
  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ¸ß½ÃÄÚ
  • ¾Æ¸£ÇîÆ¼³ª
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¿µ±¹
  • µ¶ÀÏ
  • ÀÌÅ»¸®¾Æ
  • ÇÁ¶û½º
  • ½ºÆäÀÎ
  • ·¯½Ã¾Æ
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • ASEAN
  • È£ÁÖ
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • GCC
  • À̽º¶ó¿¤
  • ±âŸ Áßµ¿
  • ¾ÆÇÁ¸®Ä«
  • ºÏ¾ÆÇÁ¸®Ä«
  • Áß¾Ó ¾ÆÇÁ¸®Ä«
  • ³²¾ÆÇÁ¸®Ä«

Á¦10Àå °æÀï ±¸µµ

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Pfizer Inc.
    • Atom pharma
    • Perrigo Company plc
    • Johnson and Johnson Services, Inc.
    • Merck KGaA
    • Actavis Pharma, Inc.
    • Apotex Inc.
    • UltiMed Inc.
    • DS LABORATORIES, INC.
    • Taisho Pharmaceutical Co., Ltd.
    • NIKSAN PHARMACEUTICAL
    • SALVAVIDAS PHARMACEUTICAL PVT. LTD.
    • Maruti Futuristic Pharma Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Lupin
    • Steris Healthcare PVT Ltd
    • Salvus Pharma
    • Unison Pharmaceuticals Pvt Ltd
    • Par Pharmaceutical
    • QndQ Derma

Á¦11Àå ¼½¼Ç

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
BJH 23.11.23

The global minoxidil market is estimated to be valued at US$ 1,095.5 million in 2023 and is expected to exhibit a CAGR of 4.8% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1,095.5 Mn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 4.80% 2030 Value Projection: US$ 1,521.1 Mn
Figure 1. Global Minoxidil Market Share (%), By Type, 2023
Minoxidil Market - IMG1

Minoxidil is a medication used for the treatment of high blood pressure and pattern hair loss. It is an antihypertensive vasodilator. It is available as a generic medication by prescription in the oral tablet form and over-the-counter as a topical liquid or foam. Minoxidil, an antihypertensive topical formulation, promotes hair growth. Minoxidil is majorly prescribed for the treatment of androgenetic alopecia, and it is also used as an off-label treatment for other hair loss conditions. Minoxidil is a U.S. Food and Drug Administration (FDA) approved, 2% minoxidil solution and was first launched in the market in 1986, followed by the 5% solution in 1993, and it is majorly applicable in hair growth promotion.

Market Dynamics

The increasing adoption of organic growth strategies, such as product launches, by key market players to expand their product portfolios is expected to drive the market growth over the forecast period. For instance, in November 2020, Bosley, the largest hair restoration company in the U.S., launched BosleyRx, the modern-day approach to prescription hair loss medications for men. Through a simple online process, an experienced medical professional can diagnose and prescribe hair loss prevention and growth treatments.

Key features of the study:

  • This report provides an in-depth analysis of the global minoxidil market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global minoxidil market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • The key companies covered as a part of this study include Pfizer Inc., Atom pharma, Perrigo Company plc, Johnson and Johnson Services, Inc., Merck KGaA, Actavis Pharma, Inc., Apotex Inc., UltiMed Inc., DS LABORATORIES, INC., Taisho Pharmaceutical Co., Ltd., NIKSAN PHARMACEUTICAL, SALVAVIDAS PHARMACEUTICAL PVT. LTD., Maruti Futuristic Pharma Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Lupin, Steris Healthcare PVT Ltd, Salvus Pharma, Unison Pharmaceuticals Pvt Ltd, Par Pharmaceutical, and QndQ Derma
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global minoxidil market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global minoxidil market

Global Minoxidil Market Detailed Segmentation:

  • By Type:
    • 5% Minoxidil
    • 2% Minoxidil
  • By Route of Administration:
    • Oral
    • Topical
  • By Gender:
    • Male
    • Female
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Pfizer Inc.
    • Atom pharma
    • Perrigo Company plc
    • Johnson and Johnson Services, Inc.
    • Merck KGaA
    • Actavis Pharma, Inc.
    • Apotex Inc.
    • UltiMed Inc.
    • DS LABORATORIES, INC.
    • Taisho Pharmaceutical Co., Ltd.
    • NIKSAN PHARMACEUTICAL
    • SALVAVIDAS PHARMACEUTICAL PVT. LTD.
    • Maruti Futuristic Pharma Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Reddy's Laboratories Ltd.
    • Lupin
    • Steris Healthcare PVT Ltd
    • Salvus Pharma
    • Unison Pharmaceuticals Pvt Ltd
    • Par Pharmaceutical
    • QndQ Derma

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Gender
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Mergers, Acquisitions, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Minoxidil Market - COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Minoxidil Market, By Type, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • 5% Minoxidil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • 2% Minoxidil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

6. Global Minoxidil Market, By Route of Administration, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

7. Global Minoxidil Market, By Gender, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Male
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Female
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

8. Global Minoxidil Market, By Distribution Channel, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)

9. Global Minoxidil Market, By Region, 2018 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018-2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast,Y-o-Y Growth and By Type, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018-2030, (US$ Mn)
    • Market Size and Forecast, Y-o-Y Growth and By Gender, 2018-2030, (US$ Mn)
    • Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2018-2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profiles
    • Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Atom pharma
    • Perrigo Company plc
    • Johnson and Johnson Services, Inc.
    • Merck KGaA
    • Actavis Pharma, Inc.
    • Apotex Inc.
    • UltiMed Inc.
    • DS LABORATORIES, INC.
    • Taisho Pharmaceutical Co., Ltd.
    • NIKSAN PHARMACEUTICAL
    • SALVAVIDAS PHARMACEUTICAL PVT. LTD.
    • Maruti Futuristic Pharma Pvt. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Lupin
    • Steris Healthcare PVT Ltd
    • Salvus Pharma
    • Unison Pharmaceuticals Pvt Ltd
    • Par Pharmaceutical
    • QndQ Derma

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦